Swiss National Bank
DNA icon

Swiss National Bank’s Ginkgo Bioworks DNA Stock Holding History

Swiss National Bank’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$399K Hold
65,063
– – ﹤0.01% 2290
2025
Q4 		$541K Buy
65,063
+6,600
+11% +$71.1K ﹤0.01% 2282
2025
Q3 		$852K Buy
58,463
+1,600
+3% +$19.1K ﹤0.01% 2214
2025
Q2 		$640K Sell
56,863
-4,500
-7% -$34.9K ﹤0.01% 2276
2025
Q1 		$350K Buy
61,363
+6,500
+12% +$66.2K ﹤0.01% 2380
2024
Q4 		$539K Hold
54,863
– – ﹤0.01% 2394
2024
Q3 		$447K Buy
54,863
+2,100
+4% +$21K ﹤0.01% 2448
2024
Q2 		$706K Buy
52,763
+800
+2% +$23.9K ﹤0.01% 2326
2024
Q1 		$2.41M Buy
51,963
+693
+1% +$35.9K ﹤0.01% 1736
2023
Q4 		$3.47M Sell
51,270
-5,353
-9% -$328K ﹤0.01% 1513
2023
Q3 		$4.1M Buy
56,623
+5,348
+10% +$428K ﹤0.01% 1399
2023
Q2 		$3.81M Buy
51,275
+6,077
+13% +$360K ﹤0.01% 1473
2023
Q1 		$2.4M Sell
45,198
-4,330
-9% -$274K ﹤0.01% 1725
2022
Q4 		$3.35M Buy
49,528
+13,873
+39% +$1.28M ﹤0.01% 1558
2022
Q3 		$4.45M Buy
35,655
+660
+2% +$78.7K ﹤0.01% 1347
2022
Q2 		$3.33M Buy
+34,995
New +$4.27M ﹤0.01% 1574

Other funds holding DNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.18B AUM 27.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Swiss National Bank's DNA Position: Q1 2026 in Review

Swiss National Bank held its Ginkgo Bioworks (DNA) position steady in Q1 2026 at 65,063 shares worth $399K. The position accounts for ﹤0.01% of the portfolio, ranked #2290.

Swiss National Bank first reported a position in DNA in Q2 2022 and has held it in 16 quarters since. The position peaked at $4.45M in Q3 2022. 174 funds tracked by Wall St. Rank hold DNA as of Q1 2026.

  • Swiss National Bank held 65,063 shares of Ginkgo Bioworks worth $399K as of Q1 2026.
  • Swiss National Bank left its Ginkgo Bioworks share count unchanged in Q1 2026.
  • Ginkgo Bioworks made up ﹤0.01% of Swiss National Bank's portfolio in Q1 2026, its #2290 holding.
  • Swiss National Bank first reported a position in Ginkgo Bioworks in Q2 2022 and has held it in 16 quarters since.
  • Swiss National Bank's Ginkgo Bioworks position peaked at $4.45M in Q3 2022.
  • 174 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q1 2026.

Based on Swiss National Bank's 13F filing for Q1 2026, filed 7 May 2026.